Tag: Pharma
-
Glenmark Pharma launches digital inhaler for asthma patients – Times of India
Times of India Glenmark Pharma launches digital inhaler for asthma patientsTimes of IndiaGlenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, launched what the company touted as India's first Digital Dose Inhaler for asthma and pulmonary disease patients. The inhaler, branded as Digihaler, provides …Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.comGlenmark's new 'digital dose inhaler' […]
-
Pharma firms come out with apps for asthma patients – The Hindu
Pharma firms come out with apps for asthma patientsThe HinduWith the number of asthma patients rising by the day, pharmaceutical companies are coming out with mobile apps to connect them with doctors for timely medical help. According to estimates, 50 to 70 per cent of asthma patients in India do not adhere to …Sun rolls out […]
-
Sun Pharma launches mobile app for asthma patients – Financial Express
ETCIO.com Sun Pharma launches mobile app for asthma patientsFinancial ExpressAs part of its focus to give boost to treatment compliance amongst Asthma patients by minimising instances of non-adherence and drop-outs in Asthma treatment regime, Sun Pharma Sun Pharma is rolling out India's first unique and innovative mobile …Sun Pharma's RespiTrack mobile app to boost treatment compliance […]
-
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11 – StreetInsider.com
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11StreetInsider.com“The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of […]
-
ALK’s Grazax in five-year landmark asthma prevention trial in children sees … – The Pharma Letter (registration)
ALK's Grazax in five-year landmark asthma prevention trial in children sees …The Pharma Letter (registration)Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass pollen allergy. The GAP trial consisted of a … View full post on asthma – Google […]
-
GSK gets European marketing rights for Nucala to treat asthma – The Pharma Letter (registration)
The Pharma Letter (registration) GSK gets European marketing rights for Nucala to treat asthmaThe Pharma Letter (registration)UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the …EU […]
-
Ajanta Pharma launches generic asthma treatment tablets in US – Economic Times
Ajanta Pharma launches generic asthma treatment tablets in USEconomic TimesNEW DELHI: Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast …Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.comAjanta Pharma launches […]
-
Ajanta Pharma launches generic asthma drug in US market – ETHealthWorld.com
ETHealthWorld.com Ajanta Pharma launches generic asthma drug in US marketETHealthWorld.comNew Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …Ajanta Pharma launches […]
-
Ajanta Pharma Launches Generic Asthma Drug in US Market – NDTV
Ajanta Pharma Launches Generic Asthma Drug in US MarketNDTVNew Delhi: Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …and more » View full post on […]
-
Ajanta Pharma bags USFDA nod For Asthma Treatment Pill – The Wiire (blog)
The Wiire (blog) Ajanta Pharma bags USFDA nod For Asthma Treatment PillThe Wiire (blog)Drug giant Ajanta Pharma has bagged final nods from the US health watchdog for generic montelukast pills and oral granules utilized for deterrence as well as cure of asthma and to ease indications of seasonal pollinosis.Ajanta Pharma Gets US Regulator's Nod for […]